Stock Track | Pacira Pharmaceuticals (PCRX) Plunges 5.03% on Monday Amid Class Action Lawsuit

Stock Track

03/04

Pacira Pharmaceuticals (PCRX) stock plummeted 5.03% on Monday, following the news of a class action lawsuit filed against the company.

According to the report, a class action lawsuit was filed against Pacira Biosciences, Inc. (PCRX) by Levi & Korsinsky on January 13, 2025. The lawsuit alleges certain claims against the company and its executives, potentially posing legal and financial risks for Pacira Pharmaceuticals.

The market reacted negatively to the news, as investors seemingly expressed concern over the potential implications of the lawsuit on the company's operations and financial performance. The stock experienced a significant sell-off, resulting in a 5.03% decline in its share price on Monday.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1195156426"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1195156426\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1195156426?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-04 04:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195156426","market":"us","top_or_hot":-1,"title":"Stock Track | Pacira Pharmaceuticals (PCRX) Plunges 5.03% on Monday Amid Class Action Lawsuit","media":"Stock Track","content":"<p>Pacira Pharmaceuticals (PCRX) stock plummeted 5.03% on Monday, following the news of a class action lawsuit filed against the company.</p>\n\n<p>According to the report, a class action lawsuit was filed against Pacira Biosciences, Inc. (PCRX) by Levi & Korsinsky on January 13, 2025. The lawsuit alleges certain claims against the company and its executives, potentially posing legal and financial risks for Pacira Pharmaceuticals.</p>\n\n<p>The market reacted negatively to the news, as investors seemingly expressed concern over the potential implications of the lawsuit on the company's operations and financial performance. The stock experienced a significant sell-off, resulting in a 5.03% decline in its share price on Monday.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Pacira Pharmaceuticals (PCRX) Plunges 5.03% on Monday Amid Class Action Lawsuit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Pacira Pharmaceuticals (PCRX) Plunges 5.03% on Monday Amid Class Action Lawsuit\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2025-03-04 04:46</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Pacira Pharmaceuticals (PCRX) stock plummeted 5.03% on Monday, following the news of a class action lawsuit filed against the company.</p>\n\n<p>According to the report, a class action lawsuit was filed against Pacira Biosciences, Inc. (PCRX) by Levi & Korsinsky on January 13, 2025. The lawsuit alleges certain claims against the company and its executives, potentially posing legal and financial risks for Pacira Pharmaceuticals.</p>\n\n<p>The market reacted negatively to the news, as investors seemingly expressed concern over the potential implications of the lawsuit on the company's operations and financial performance. The stock experienced a significant sell-off, resulting in a 5.03% decline in its share price on Monday.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PCRX","symbol_name":"Pacira Pharmaceuticals","start_time":0,"source_url":"","article_id":"1195156426","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195156426","pubTimestamp":1741034800,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Pacira Pharmaceuticals  stock plummeted 5.03% on Monday, following the news of a class action lawsuit filed against the company.According to the report, a class action lawsuit was filed against Pacira Biosciences, Inc.  by Levi & Korsinsky on January 13, 2025. The lawsuit alleges certain claims against the company and its executives, potentially posing legal and financial risks for Pacira Pharmaceuticals.The market reacted negatively to the news, as investors seemingly expressed concern over the","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PCRX":"Pacira Pharmaceuticals"},"translate_title":"股票追踪Pacira Pharmaceuticals(PCRX)周一因集体诉讼暴跌5.03%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PCRX":1},"content_text":"Pacira Pharmaceuticals (PCRX) stock plummeted 5.03% on Monday, following the news of a class action lawsuit filed against the company.\nAccording to the report, a class action lawsuit was filed against Pacira Biosciences, Inc. (PCRX) by Levi & Korsinsky on January 13, 2025. The lawsuit alleges certain claims against the company and its executives, potentially posing legal and financial risks for Pacira Pharmaceuticals.\nThe market reacted negatively to the news, as investors seemingly expressed concern over the potential implications of the lawsuit on the company's operations and financial performance. The stock experienced a significant sell-off, resulting in a 5.03% decline in its share price on Monday.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}